Last93.11 +0.82 (+0.89%)
19.68 - 108.47
52 Week Range
Technical Indicators (Daily)
NEW HAVEN, Conn., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today ann...
Shareholders in Arvinas, Inc. ( NASDAQ:ARVN ) may be thrilled to learn that the analysts have just delivered a major......
Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine's AI-augmented platforms and close cooperation betwee...
Arvinas, Inc. (ARVN) delivered earnings and revenue surprises of -22.62% and 2.93%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...
NEW HAVEN, Conn., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today repo...
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.